Showing 241 - 260 results of 2,138 for search '"Chronic Myeloid Leukemia"', query time: 0.42s Refine Results
  1. 241
  2. 242

    Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib by Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, Francis Giles

    Published 2009-03-01
    “…The purpose of this review is to summarize the pre-clinical and clinical data on nilotinib in patients with CML who have failed prior therapy with IM or dasatinib.Keywords: nilotinib, chronic myeloid leukemia, imatinib…”
    Get full text
    Article
  3. 243
  4. 244

    Nilotinib-Induced Acute Interstitial Nephritis during the Treatment of Chronic Myeloid Leukemia by Min Jeong Kim

    Published 2021-12-01
    “…We report a case of a 39-year-old man with acute kidney injury that developed after nilotinib treatment for chronic myeloid leukemia (CML). The renal function of the patient decreased during treatment with nilotinib but improved when treatment was discontinued due to neutropenia. …”
    Get full text
    Article
  5. 245

    Effects of nilotinib on platelet function in patients with chronic myeloid leukemia in chronic phase by Alauldeen Mudhafar Zubair Alqasim, Ghasaq Mohsin Obaid, Yusra Ghaith Yaseen, Alaa Fadhil Alwan

    Published 2019-01-01
    “…Patients and methods: This study was conducted on 42 patients diagnosed as Chronic Phase of Chronic Myeloid Leukemia based on clinical, morphological and cytogenetic study. …”
    Get full text
    Article
  6. 246

    Subjective intermittent colour vision loss as the initial presentation of chronic myeloid leukemia by Solin Saleh, Kaisra Esmail, Danah Albreiki

    Published 2020-09-01
    “…Purpose: To report a case of subjective intermittent loss of bilateral colour vision and episodic white-out vision in a patient with undiagnosed chronic myeloid leukemia (CML). Observations: A patient initially diagnosed with diabetic retinopathy presented with a chief complaint of subjective intermittent loss of colour vision in both eyes, as well as intermittent bilateral white-out vision. …”
    Get full text
    Article
  7. 247

    Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia by Meinolf Suttorp, Frédéric Millot, Stephanie Sembill, Hélène Deutsch, Markus Metzler

    Published 2021-02-01
    “…Depending on the analytical tool applied, the hallmarks of chronic myeloid leukemia (CML) are the Philadelphia Chromosome and the resulting mRNA fusion transcript BCR-ABL1. …”
    Get full text
    Article
  8. 248
  9. 249
  10. 250

    Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia by matteo molica, elisabetta abruzzese, massimo breccia

    Published 2020-08-01
    Subjects: “…chronic myeloid leukemia, transcript type, e13a2, e14a2, treatment-free remission…”
    Get full text
    Article
  11. 251

    Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations by Elisabetta Abruzzese, Michael Mauro, Jane Apperley, Ekaterina Chelysheva

    Published 2020-10-01
    “…With survival expectation that of age-matched controls and given excellent response and worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly important for a considerable fraction of patients with chronic myeloid leukemia (CML). The potential for therapy discontinuation (“treatment free remission”) can afford the opportunity for a CML patient in deep response to plan and carry a pregnancy to full term without any therapeutic interventions. …”
    Get full text
    Article
  12. 252

    First-line therapy of chronic myeloid leukemia – focus on dasatinib by Amrein PC

    Published 2012-04-01
    “…This activity has allowed dasatinib to emerge as one of the most effective agents in the treatment of chronic myeloid leukemia (CML), and dasatinib has become the third drug over the past 10 years to be FDA approved for first line therapy in this setting. …”
    Get full text
    Article
  13. 253
  14. 254

    Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives by Ahmed Adel Elsabagh, Maria Benkhadra, Ibrahim Elmakaty, Abdelrahman Elsayed, Basant Elsayed, Mohamed Elmarasi, Mohammad Abutineh, Nabeel Mohammad Qasem, Elrazi Ali, Mohamed Yassin

    Published 2024-02-01
    “…Chronic myeloid leukemia (CML), while traditionally a disease of the elderly, has recently risen in incidence among younger patients. …”
    Get full text
    Article
  15. 255

    Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia by Michele Massimino, Stefania Stella, Elena Tirrò, Chiara Romano, Maria Stella Pennisi, Adriana Puma, Livia Manzella, Antonino Zanghì, Fabio Stagno, Francesco Di Raimondo, Paolo Vigneri

    Published 2018-02-01
    “…Abstract The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory hematological, cytogenetic and molecular remissions. …”
    Get full text
    Article
  16. 256
  17. 257
  18. 258
  19. 259
  20. 260